Combination efficacy of ruxolitinib with standard-of-care drugs in CRLF2-rearranged Ph-like acute lymphoblastic leukemia

Julia Böhm, Keith C.S. Sia, Connor Jones, Kathryn Evans, Anna Mariana, Chi Nam Ignatius Pang, Tim Failes, Ling Zhong, Chelsea Mayoh, Robert Landman, Robert J. Collins, Stephen W. Erickson, Greg M. Arndt, Mark J. Raftery, Marc R. Wilkins, Murray D. Norris, Michelle Haber, Glenn M. Marshall, Richard B. Lock